NOVO INDUSTRI EARNINGS FALL DESPITE INCREASED SALES COPENHAGEN MARCH 11 DANISH BASED INSULIN AND ENZYMES PRODUCER NOVO INDUSTRI A S NVOCO SAID PRE TAX EARNINGS FELL ALMOST 10 PCT IN 1986 THOUGH SALES ROSE BY TWO PCT THE PRE TAX FIGURE FELL TO 788 MLN CROWNS FROM 872 MLN IN 1985 ON SALES INCREASED FROM 41 BILLION TO 42 BILLION GIVING NET EARNINGS OF 521 MLN CROWNS AGAINST 604 MLN IN 1985 EARNINGS PER 20 CROWN SHARE WENT FROM 2379 CROWNS TO 2045 CROWNS BUT THE COMPANY PROPOSED AN UNCHANGED 20 PCT DIVIDEND FOREIGN EXCHANGE FLUCTUATIONS IN 1986 WERE A VERY SIGNIFICANT FACTOR BEHIND DEVELOPMENTS IN THE RESULT BEFORE AND AFTER TAX NOVO SAID IN A STATEMENT NOT ONLY THE US DOLLAR BUT ALSO OTHER CURRENCIES ESSENTIAL TO NOVO FELL IN 1986 IN RELATION TO THE DANISH CROWN THE STATEMENT ADDED IN NOVEMBER 1986 NOVO PURCHASED 75 PCT OF SHARES IN A S FERROSAN WHICH HEADS A GROUP SPECIALISING IN RESEARCH AND DEVELOPMENT OF CNS CENTRAL NERVOUS TREATMENT TREATMENTS AND THE SALE OF PHARMACEUTICALS AND VITAMINS IN SCANDINAVIA THE 357 MLN CROWNS PAID IN GOODWILL HAD A VERY LIMITED EFFECT ON THE 1986 RESULT THE NOVO STATEMENT SAID   